Anti-inflammatory effect of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitive CRP: The PIOSTAT study. - Hanefeld,M.; Marx,N.; Pfützner,A.; Baurecht,W.; Lübben,G.; Karagiannis,E.; Stier,U.; Forst,T. (J Am Coll Cardiol, 2007)